XGenomes is bringing DNA sequencing to the masses

As healthcare moves toward genetically tailored treatments, one of the biggest hurdles to truly personalized medicine is the lack of fast, low-cost genetic testing. And few people are more familiar with the problems of today’s genetic diagnostics tools than Kalim Mir, the 52-year-old founder of XGenomes, who has spent his entire professional career studying the […]

View More XGenomes is bringing DNA sequencing to the masses

Sophia Genetics bags $77M Series E, with 850+ hospitals signed up to its “data-driven medicine”

Another sizeable cash injection for big data biotech: Sophia Genetics has announced a $77M Series E funding round, bringing its total raised to $140M since the business was founded back in 2011. The company, which applies AI to DNA sequencing to enable what it dubs “data-driven medicine”, last closed a $30M Series D in fall 2017. […]

View More Sophia Genetics bags $77M Series E, with 850+ hospitals signed up to its “data-driven medicine”

23andMe might soon offer a more comprehensive $749 DNA service

23andMe is testing a $749 “premium” service for deeper health insights, according to several customers who saw a test page for the new product and posted about it on Reddit. First spotted by CNBC, the company served up a test web page to several customers telling them about a service that would allow them to […]

View More 23andMe might soon offer a more comprehensive $749 DNA service

The genomics-focused Illumina Accelerator backs five new companies

Illumina Accelerator, the genomics-focused startup accelerator backed by the publicly traded genetic sequencing pioneer Illumina Corp., has picked five startups for its seventh accelerator class, the company announced. Wth technology addressing skin microbial therapeutics, fertility science, chronic disease alleviation, post traumatic stress disorder treatments, and services for the biopharmaceutical and clinical research industries; the startups […]

View More The genomics-focused Illumina Accelerator backs five new companies